Copyright © Inderes 2011 - present. All rights reserved.
  • Senaste
  • Börs
    • Aktiejämförelse
    • Börskalender
    • Utdelningskalender
    • Aktieanalys
    • Artiklar
  • InderesTV
  • Portfölj
  • Forum
  • Q&A
  • Om oss
    • Bolag under bevakning
    • Teamet
Analytikerkommentar

NeoDynamics receives new order from large hospital in Germany

Av Claus ThestrupCEO, Sweden
NeoDynamics

NeoDynamics receives new order from large hospital in Germany.

Order momentum starts to build-up in Europe and NeoDynamics clearly shows the Pro's with the NeoNavia system in breast biopsies and especially the Flexipulse needle.

CEO Anna Eriksrud commented on the order “We are very pleased to announce yet another order for FlexiPulse needles from Germany. Western Rhineland-Palatinate Hospital is among the top 100 rated and distinguished hospitals in Germany and it serves as academic training hospital for the University of Mains. It has a large interdisciplinary sonography department performing all kinds of biopsies. This order clearly demonstrates the commercial viability of our innovative pulse technology and its increasing acceptance by leading practitioners” says Anna Eriksrud, CEO."

Read more: https://www.neodynamics.com/en-gb/press-releases/article/868e3c84-b292-4707-a5f1-6225cd23aee0/neodynamics-receives-new-order-from-large-hospital-in-germany

Disclaimer: HC Andersen Capital receives payment from NeoDynamics for a Digital IR/Corporate Visibility subscription agreement. Claus Thestrup 8:20 AM 19-10-2023.

NeoDynamics AB (publ) is a Swedish Medical Technology Company dedicated to advancing diagnosis and care of breast cancer. The company’s first product NeoNavia®, a new innovative pulse biopsy system for ultrasound guided tissue sampling, is currently being introduced to the market. The biopsy system is built on a patented pulse technology, based on research at the Karolinska Institutet in Sweden.

Läs mera
Följ oss på våra kanaler i social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Ta kontakt
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • Om oss
  • Teamet
  • Jobba hos oss
  • Inderes som en investering
  • Tjänster för börsbolag
Vår plattform
  • FAQ
  • Servicevillkor
  • Integritetspolicy
  • Disclaimer
Inderes disclaimer gällande utförda aktieanalyser kan läsas här. För mer detaljerad information över de aktier som aktivt bevakas av Inderes, vänligen se respektive bolags bolagsspecifika sida på Inderes webbplats. © Inderes Oyj. Alla rättigheter förbehållna.